Comparative Effectiveness Research as a Drug Development Tool
A Q&A with John Doyle, Senior Vice President and Practice Leader, Commercial and Market Access Strategy, Consulting at Quintiles, sheds light on the complex issue of comparative effectiveness research, and its strategic importance in successful and efficient biopharmaceutical development.
Embedded player: Either you don't have Flash installed, or it's being blocked by your browser. But you can still...
